Evidence map›Paper›PMID 38304624›Full record

ArticleCytotechnology2024

Construction of a novel kinetic model for the production process of a CVA6 VLP vaccine in CHO cells.

Zhou Xing, Thao Bich Nguyen, Guirong Kanai-Bai, Noriko Yamano-Adachi, Takeshi Omasa

Abstract read
In one paragraph

Article in Cytotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhou XingGraduate School of Engineering, Osaka University, U1E801, 2-1Yamadaoka, Suita, Osaka 565-0871 Japan.ORCID 0009-0008-9287-4261
Thao Bich NguyenGraduate School of Engineering, Osaka University, U1E801, 2-1Yamadaoka, Suita, Osaka 565-0871 Japan.ORCID 0009-0001-1516-4986
Guirong Kanai-BaiGraduate School of Engineering, Osaka University, U1E801, 2-1Yamadaoka, Suita, Osaka 565-0871 Japan.ORCID 0009-0000-5216-1090
Noriko Yamano-AdachiGraduate School of Engineering, Osaka University, U1E801, 2-1Yamadaoka, Suita, Osaka 565-0871 Japan.ORCID 0000-0002-2167-5379
Takeshi OmasaGraduate School of Engineering, Osaka University, U1E801, 2-1Yamadaoka, Suita, Osaka 565-0871 Japan.ORCID 0000-0003-0635-3862

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioprocess development benefits from kinetic models in many aspects, including scale-up, optimization, and process understanding. However, current models are unable to simulate the production process of a coxsackievirus A6 (CVA6) virus-like particle (VLP) vaccine using Chinese hamster ovary cell culture. In this study, a novel kinetic model was constructed, correlating (1) cell growth, death, and lysis kinetics, (2) metabolism of major metabolites, and (3) CVA6 VLP production. To construct the model, two batches of a laboratory-scale 2 L bioreactor cell culture were prepared and various pH shift strategies were applied to examine the effect of pH shift. The proposed model described the experimental data under various conditions with high accuracy and quantified the effect of pH shift. Next, cell culture performance with various pH shift timings was predicted by the calibrated model. A trade-off relationship was found between product yield and quality. Consequently, multiple objective optimization was performed by integrating desirability methodology with model simulation. Finally, the optimal operating conditions that balanced product yield and quality were predicted. In general, the proposed model improved the process understanding and enabled in silico process development of a CVA6 VLP vaccine. Supplementary Information: The online version contains supplementary material available at 10.1007/s10616-023-00598-8.

Indexed as

Bioprocess modelingChinese hamster ovary cell cultureProcess optimizationVaccine productionVirus-like particle

Identifiers

PMID38304624
PMCPMC10828271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.